Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

Anticonvulsant levetiracetam may also improve learning and memory in patients with Alzheimer’s

Staff Writer
Staff Writer 1 year ago
Updated 2021/09/30 at 1:13 AM
Share
SHARE

An anticonvulsant often used to treat seizures may also improve learning and memory in patients with Alzheimer’s disease (AD), a new study in JAMA Neurology unveiled.

Known as levetiracetam, the drug is used to treat different types of epilepsy, including focal, partial-complex, and generalized epilepsy. But its recent focus on reducing hyperactivity in the hippocampus of patients with Alzheimer’s disease suggests levetiracetam may serve other functions.

For the study, 34 adults with Alzheimer’s were recruited to have levetiracetam administered at a low dose for a span of four weeks.

Among the participants with Alzheimer’s, the treatment improved executive function and spatial memory.


“This study’s findings indicated that extended neurophysiological assessments are important to identify patients with AD who could benefit from antiseizure approaches and that levetiracetam treatment could improve cognitive symptoms in the estimated 60% of patients with AD who have seizures and subclinical epileptiform activity,” according to the JAMA findings.

“These exploratory findings warrant further assessment of antiseizure approaches in AD.”

You Might Also Like

New study explores test that can detect Alzheimer’s years before diagnosis

New research explores the association between viral infection and Alzheimer’s disease

Prenatal exposure to pollution may be linked to lower cognitive scores in infants

Researchers unveil new drug candidate to help treat adrenoleukodystrophy

New research finds Alzheimer’s risk factors affect males and females very differently

TAGGED: Alzheimer's disease, cognition, epilepsy, memory
Staff Writer September 29, 2021
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article New research shows how type 2 diabetes may be linked to Alzheimer’s disease
Next Article Menopausal hormone therapy does not increase the risk of dementia

Recommended

Clinical

New study explores test that can detect Alzheimer’s years before diagnosis

1 Min Read
Health

New research explores the association between viral infection and Alzheimer’s disease

1 Min Read
Clinical

Prenatal exposure to pollution may be linked to lower cognitive scores in infants

1 Min Read
Clinical

Researchers unveil new drug candidate to help treat adrenoleukodystrophy

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?